Publications for Ang, K K
|Up a level|
Raju, Uma; Riesterer, Oliver; Wang, Zhi-Qiang; Molkentine, David P; Molkentine, Jessica M; Johnson, Faye M; Glisson, Bonnie; Milas, Luka; Ang, K Kian (2012). Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiotherapy and Oncology, 105(2):241-249.
Torres, M A; Raju, U; Molkentine, D; Riesterer, O; Milas, L; Ang, K K (2011). AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Investigational New Drugs, 29(4):554-561.
Riesterer, O; Yang, Q; Raju, U; Torres, M; Molkentine, D; Patel, N; Valdecanas, D; Milas, L; Ang, K K (2011). Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers. International Journal of Radiation Oncology, Biology and Physics, 79(4):1179-1187.
Riesterer, O; Mason, K A; Raju, U; Yang, Q; Wang, L; Hittelman, W N; Ang, K K; Milas, L (2009). Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed. Radiotherapy and Oncology, 92(3):383-387.
Bernier, J; Bonner, J; Vermorken, J B; Bensadoun, R J; Dummer, R; Giralt, J; Kornek, G; Hartley, A; Mesia, R; Robert, C; Segaert, S; Ang, K K (2008). Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Annals of Oncology, 19(1):142-149.